Sources and updates, February 5
Sources and updates for the week of February 5 include modeling persistent COVID-19 risk, global vaccination coverage, COVID-related lawsuits, and more.
Read MoreTag: global health
Russia’s invasion of Ukraine has COVID-19 impacts
When Russian troops began attacking Ukraine, the country was just recovering from its worst COVID-19 surge of the pandemic. To state the terrifying obvious: war makes it much harder to control a pandemic.
Read MoreWe failed to vaccinate the world in 2021; will 2022 be more successful?
In January, COVAX set a goal that many global health advocates considered modest: delivering 2.3 billion vaccine doses to low- and middle-income countries by the end of 2021. is saying it’ll deliver just 800 million vaccine doses by the end of 2021, according to the Washington Post, and only about 600 million had been delivered by early December.
Read MoreSources and updates, December 12
Featured sources for the week of December 12 include booster shot trends, global health security, children orphaned by COVID-19, and alcohol laws.
Read MoreOmicron variant: What we know, what we don’t, and why not to panic (yet)
On Thanksgiving, my Twitter feed was dominated not by food photos, but by news of a novel coronavirus variant identified in South Africa earlier this week. While the variant—now called Omicron, or B.1.1.529—likely didn’t originate in South Africa, data from the country’s comprehensive surveillance system provided enough evidence to suggest that this variant could be more contagious than Delta, as well as potentially more able to evade human immune systems.
Read MoreFirst COVID-19 antiviral pill gains authorization
This week, an antiviral pill for COVID-19 was authorized in the U.K. The drug, made by American pharmaceutical company Merck, is the first COVID-19 treatment in pill form to gain approval by any regulatory agency.
Read More